ClinicalTrials.Veeva

Menu

Foot Muscles Training in Sclerosis

I

Inés Llamas-Ramos

Status

Enrolling

Conditions

Multiple Sclerosis
Muscle Weakness
Training Group, Sensitivity

Treatments

Procedure: Intrinsic Mucle Training

Study type

Interventional

Funder types

Other

Identifiers

NCT06665607
FOOT TRAINING-SCLEROSIS

Details and patient eligibility

About

The study tries to assess the efficacy of an 8-week IFM training programme on stability in patients diagnosed with Multiple Sclerosis

Enrollment

34 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with moderate neurological disability as scored by the Expanded Disability Status Scale (EDSS), ranging from 3.0 to 6.0

Exclusion criteria

  • Cognitive disturbances that could affect the performance of any of the tests or questionnaires included in the study
  • Diagnosis of visual or vestibular disorders that could affect patient stability
  • Change in Multiple Sclerosis-specific medication in the 2 months prior to the start of the study
  • Acute relapse in the 2 months prior to the start of the study
  • Traumatologic or orthopaedic disorders that could negatively affect balance.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

34 participants in 2 patient groups

Training Group
Experimental group
Treatment:
Procedure: Intrinsic Mucle Training
Control Group
Sham Comparator group
Treatment:
Procedure: Intrinsic Mucle Training

Trial contacts and locations

1

Loading...

Central trial contact

Daniel García García, PhD; Inés Llamas Ramos, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems